Filing Details
- Accession Number:
- 0000899243-22-016635
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-04 17:07:22
- Reporting Period:
- 2022-05-02
- Accepted Time:
- 2022-05-04 17:07:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1223348 | Jr F Charles Wagner | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-02 | 20 | $254.87 | 43,053 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 100 | $257.18 | 42,953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 60 | $258.21 | 42,893 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 80 | $259.45 | 42,813 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 48 | $261.15 | 42,765 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 32 | $262.06 | 42,733 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 3 | $264.37 | 42,730 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1.
- Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $257.18 (range $256.68 to $257.47).
- Open market sales reported on this line occurred at a weighted average price of $258.21 (range $257.98 to $258.61).
- Open market sales reported on this line occurred at a weighted average price of $259.45 (range $258.98 to $259.90).
- Open market sales reported on this line occurred at a weighted average price of $261.15 (range $260.79 to $261.63).
- Open market sales reported on this line occurred at a weighted average price of $262.06 (range $261.89 to $262.23).
Billionaire Hedge Funds
